G12DNRAS and kinase-dead BRAF cooperate to drive naevogenesis and melanomagenesis

Pigment Cell and Melanoma Research

Volumn 27, Issue 6, 2014, Pages 1162-1166

  Pedersen, Malin ^a   Viros, Amaya ^b   Cook, Martin ^b,c   Marais, Richard ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, MOUSE; RAS PROTEIN;

CARCINOGENESIS; GENE MUTATION; LETTER; MELANOCYTE; MELANOMA; NEVUS; NONHUMAN; ONCOGENE N RAS; SKIN PIGMENTATION; AMINO ACID SUBSTITUTION; ANIMAL; CELL PROLIFERATION; GENETIC ASSOCIATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PIGMENTATION;

AMINO ACID SUBSTITUTION; ANIMALS; CARCINOGENESIS; CELL PROLIFERATION; GENETIC ASSOCIATION STUDIES; MELANOMA; MICE; NEVUS; PIGMENTATION; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

EID: 84911434952     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12293     Document Type: Letter

References (14)

1. Adameyko, I., and Lallemend, F. (2010). Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes. Cell. Mol. Life Sci. 67, 3037-3055.
2. Aoki, H., Yamada, Y., Hara, A., and Kunisada, T. (2009). Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non-cutaneous and dermal versus epidermal melanocytes. Development 136, 2511-2521.
3. Cerami, E., Gao, J., Dogrusoz, U., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404.
4. Damsky, W.E. (2010). Mouse melanoma models and cell lines. Pigment Cell Melanoma Res. 23, 853-859.
5. Gao, J., Aksoy, B.A., Dogrusoz, U. et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6, pl1. doi: 10.1126/scisignal.2004088.
6. Heidorn, S.J., Milagre, C., Whittaker, S. et al. (2010). Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell 140, 209-221.
7. Larue, L., and Beermann, F. (2007). Cutaneous melanoma in genetically modified animals. Pigment Cell Res. 20, 485-497.
8. McMahon, M. (2011). Parsing out the complexity of RAF inhibitor resistance. Pigment Cell Melanoma Res. 24, 361-365.
9. Pedersen, M., Kusters-Vandevelde, H.V., Viros, A. et al. (2013). Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. Cancer Discov. 3, 458-469.
10. Sanchez-Laorden, B., Viros, A., Girotti, M.R. et al. (2014). BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling. Sci. Signal. 7, ra30.
11. Sommer, L. (2011). Generation of melanocytes from neural crest cells. Pigment Cell Melanoma Res. 24, 411-421.
12. Walker, G.J., Soyer, H.P., Terzian, T., and Box, N.F. (2011). Modelling melanoma in mice. Pigment Cell Melanoma Res. 24, 1158-1176.
13. Wan, P.T., Garnett, M.J., Roe, S.M. et al. (2004). Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855-867.
14. Whiteman, D.C., Pavan, W.J., and Bastian, B.C. (2011). The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res. 24, 879-897.